Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
arborpharma.com

See what CB Insights has to offer

Executives

5

Board of Directors

1

Arbor Pharmaceuticals Board of Director

1 Board of directors

Arbor Pharmaceuticals has 1 board of directors, including Todd Sone.

Name

Firm

Work History

Other Seats

Todd Sone

Mr. Sone, Managing Director, of Signet was previously an Investment Director at Joddes Limited, an investment holding company with interests in a number of healthcare companies, including Pharmascience, Paladin Labs, Medicom, and Oral Science. He was the Director of Strategic Planning at Pharmascience Inc., one of the largest privately-owned generic pharmaceutical companies in the world. </br></br>Prior to joining Pharmascience, Mr. Sone was a large-cap pharmaceutical analyst at Morgan Stanley. He started his career at Mercer Management Consulting serving clients across North America in the transportation and healthcare industries. </br></br>Mr. Sone received a Bachelor of Commerce (with High Distinction) from the University of Toronto and an MBA from The Wharton School at the University of Pennsylvania.

Arbor Pharmaceuticals

Name

Todd Sone

Firm

Work History

Mr. Sone, Managing Director, of Signet was previously an Investment Director at Joddes Limited, an investment holding company with interests in a number of healthcare companies, including Pharmascience, Paladin Labs, Medicom, and Oral Science. He was the Director of Strategic Planning at Pharmascience Inc., one of the largest privately-owned generic pharmaceutical companies in the world. </br></br>Prior to joining Pharmascience, Mr. Sone was a large-cap pharmaceutical analyst at Morgan Stanley. He started his career at Mercer Management Consulting serving clients across North America in the transportation and healthcare industries. </br></br>Mr. Sone received a Bachelor of Commerce (with High Distinction) from the University of Toronto and an MBA from The Wharton School at the University of Pennsylvania.

Other Seats

Arbor Pharmaceuticals

Arbor Pharmaceuticals Management Team

5 Team Members

Arbor Pharmaceuticals has 5 executives. Arbor Pharmaceuticals's founder is Richard A Franco. Arbor Pharmaceuticals's current Chief Executive Officer is Ed Schutter.

Name

Work History

Title

Status

Richard A Franco

Founder

Current

Ed Schutter

Chief Executive Officer

Current

Thom Rowland

Ventrus Biosciences, Paramount BioSciences, Solvay Pharmaceuticals, Adare Pharmaceuticals, and UCB

President, Chief Operating Officer

Current

Ben Davis

Founder

Former

Jason McCarthy

Lodgian, Acsys, and PwC

Chief Financial Officer

Former

Name

Richard A Franco

Ed Schutter

Thom Rowland

Ben Davis

Jason McCarthy

Work History

Ventrus Biosciences, Paramount BioSciences, Solvay Pharmaceuticals, Adare Pharmaceuticals, and UCB

Lodgian, Acsys, and PwC

Title

Founder

Chief Executive Officer

President, Chief Operating Officer

Founder

Chief Financial Officer

Status

Current

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.